Skip to main content
. Author manuscript; available in PMC: 2025 Nov 5.
Published in final edited form as: Curr Hepatol Rep. 2024 Apr 2;23(3):316–324. doi: 10.1007/s11901-024-00669-0

Table 3. Outcomes in study cohort.

Referred for liver transplant 31 (35%)
Underwent liver transplant 11 (13.6%)
Reason why not referred
Comorbidity 17 (19.3%)
Alcohol/substance misuse/psychosocial issues 19 (21.6%)
Frailty 8 (9.1%)
Not specified 8 (9.1%)
Recompensated 3 (3.4%)
Unspecified MDT decision 2 (2.3%)
Referred for TIPS 6 (7%)
Underwent TIPS 1 (1%)
Reasons why not referred
Substance misuse/psychosocial issues 11 (12.5%)
Serious comorbidity 12 (13.6%)
Hepatic encephalopathy 13 (14.8%)
Frailty 10 (11.4%)
Unspecified MDT decision 1 (1.1%)
Not specified 20 (22.7%)
Recompensating/improvement of refractory ascites 6 (6.8%)
Referred for transplant/listed 8 (9.1%)
Advanced liver disease 1 (1.1%)
Median number of large-volume paracentesis 5 (IQR 3–8)

MDT multi-disciplinary team, LTAD long-term ascitic drain, TIPS transjugular intrahepatic portosystemic shunt